Differentiation Of Embryonic Stem Cells To Vascular Cell Lineages

Andriana Margariti,Lingfang Zeng,Qingbo Xu
DOI: https://doi.org/10.1007/978-0-387-87429-6_44
2011-01-01
Abstract:In the face of extraordinary advances in the prevention, diagnosis, and treatment of human diseases, devastating cardiopulmonary diseases continue to deprive people of health. Research in developmental biology has led to the discovery of stem cells, which provide a platform to understand the basic mechanism of those diseases and give a hope for potential clinical applications. Three main types of stem cells have been characterized, including the embryonic stem (ES) cells, embryonic germ stein cells, and tissue-resident, or "adult," stem cells, on the basis of their origin and pluripotent ability. The source of the ES cells is the inner cell mass of a blastocyst, which is a very early embryo that contains 200-250 cells and is shaped like a hollow sphere. Embryonic germ line cells come from a human fetus that is 5-9 weeks old and are derived from tissue that would have developed into the ovaries or testes. "Adult" stem cells are derived from the umbilical cord and placenta or from blood, bone marrow, skin, and other tissues. A major distinction between the ES cells and the germ line cells is the capacity of the former to develop into every type of tissue found in an adult, whereas the latter are less versatile. Similarly, progenitor cells are characterized as pluripotent cells that can replicate and differentiate into a restricted number of cell types. This chapter will focus on the methods, mechanisms, and applications of ES cells derived from both human and mouse origins that differentiate into vascular cells.
What problem does this paper attempt to address?